NOVOZYMES -B- - Dusseldorf Stock Exchang
NOVOZYMES -B- - Dusseldorf Stock Exchang operates in Diversified Metals & Mining.
Market Cap & Net Worth: NOVOZYMES -B- - Dusseldorf Stock Exchang (NZM2)
NOVOZYMES -B- - Dusseldorf Stock Exchang (DU:NZM2) has a market capitalization of $443.78K (€432.33K) as of March 19, 2026. Listed on the DU stock exchange, this Germany-based company holds position #37725 globally and #4926 in its home market, demonstrating a -4.80% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying NOVOZYMES -B- - Dusseldorf Stock Exchang's stock price €47.41 by its total outstanding shares 9119 (9.12K).
NOVOZYMES -B- - Dusseldorf Stock Exchang Market Cap History: 2015 to 2026
NOVOZYMES -B- - Dusseldorf Stock Exchang's market capitalization history from 2015 to 2026. Data shows growth from $138.22K to $443.78K (13.82% CAGR).
NOVOZYMES -B- - Dusseldorf Stock Exchang Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how NOVOZYMES -B- - Dusseldorf Stock Exchang's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
NOVOZYMES -B- - Dusseldorf Stock Exchang's market cap is 0.00 times its annual revenue
0.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.00x
NOVOZYMES -B- - Dusseldorf Stock Exchang's market cap is 0.00 times its annual earnings
0.00x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $110.84K | $14.14 Billion | $3.05 Billion | 0.00x | 0.00x |
| 2017 | $181.18K | $14.53 Billion | $3.12 Billion | 0.00x | 0.00x |
| 2018 | $165.78K | $14.39 Billion | $3.23 Billion | 0.00x | 0.00x |
| 2019 | $214.22K | $14.37 Billion | $3.15 Billion | 0.00x | 0.00x |
| 2020 | $259.24K | $14.01 Billion | $2.83 Billion | 0.00x | 0.00x |
| 2021 | $441.78K | $14.95 Billion | $3.15 Billion | 0.00x | 0.00x |
| 2022 | $318.73K | $17.55 Billion | $3.68 Billion | 0.00x | 0.00x |
| 2023 | $431.86K | $17.90 Billion | $3.02 Billion | 0.00x | 0.00x |
Competitor Companies of NZM2 by Market Capitalization
Companies near NOVOZYMES -B- - Dusseldorf Stock Exchang in the global market cap rankings as of March 19, 2026.
Key companies related to NOVOZYMES -B- - Dusseldorf Stock Exchang by market ranking:
- BERKSHIRE HATH-A (BE:BRH): Ranked #2328 globally with a market cap of $6.43 Billion USD ( €6.27 Billion EUR).
- BERKSHIRE HATH-A - Dusseldorf Stock Exchang (DU:BRH): Ranked #2395 globally with a market cap of $6.17 Billion USD ( €6.02 Billion EUR).
- Itissalat Al-Maghrib (IAM) S.A (PINK:MAOTF): Ranked #3760 globally with a market cap of $3.25 Billion USD.
- NET ONE SYSTEMS (MU:NOX): Ranked #4660 globally with a market cap of $2.24 Billion USD ( €2.18 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #2328 | BERKSHIRE HATH-A | BE:BRH | $6.43 Billion | €634500.00 |
| #2395 | BERKSHIRE HATH-A - Dusseldorf Stock Exchang | DU:BRH | $6.17 Billion | €638000.00 |
| #3760 | Itissalat Al-Maghrib (IAM) S.A | PINK:MAOTF | $3.25 Billion | $14.80 |
| #4660 | NET ONE SYSTEMS | MU:NOX | $2.24 Billion | €1000000.00 |
NOVOZYMES -B- - Dusseldorf Stock Exchang Historical Marketcap From 2015 to 2026
Between 2015 and today, NOVOZYMES -B- - Dusseldorf Stock Exchang's market cap moved from $138.22K to $ 443.78K, with a yearly change of 13.82%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €443.78K | -12.98% |
| 2025 | €509.95K | -0.37% |
| 2024 | €511.83K | +18.52% |
| 2023 | €431.86K | +35.49% |
| 2022 | €318.73K | -27.85% |
| 2021 | €441.78K | +70.41% |
| 2020 | €259.24K | +21.02% |
| 2019 | €214.22K | +29.22% |
| 2018 | €165.78K | -8.50% |
| 2017 | €181.18K | +63.46% |
| 2016 | €110.84K | -19.81% |
| 2015 | €138.22K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of NOVOZYMES -B- - Dusseldorf Stock Exchang was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $443.78K USD |
| MoneyControl | $443.78K USD |
| MarketWatch | $443.78K USD |
| marketcap.company | $443.78K USD |
| Reuters | $443.78K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.